Epilepsy and cancer drugs on record-high shortage list amid Brexit uncertainty Medicines vital for managing epilepsy, cancer and life-threatening asthma attacks are among a record number of products which are currently facing shortages made worse by Brexit uncertainty.
The number of drugs which the government is having to subsidise through the “concession” pricing list for short supply medicines has more than doubled since October. The Independent
See also:
The number of drugs which the government is having to subsidise through the “concession” pricing list for short supply medicines has more than doubled since October. The Independent
See also:
No comments:
Post a Comment